AlgetaAlgeta is a leading company within research and development of anticancer radiopharmaceuticals based on tumor targeting with alpha particle emitters.
Alpharadin Our first product AlpharadinTM has shown promising results in the first clinical trial in patients with skeletal metastases from prostate and breast cancer.
Alpharadin videoClick on the link to view an Alpharadin video!